The following statement in table 3 has been corrected as it erroneously stated that the product label has a black box warning for constipation.
"A retrospective study from October 2018 to January 2020 evaluated 119 patients who took a CGRP mAb. Some monoclonal antibodies such as erenumab caused constipation in more than 20% of the patients and now carries a black box warning."
This error was the result of mistakenly citing an older version of the article on a health care provider website rather than the up-to-date version on the journal website. As a result, the statement has been amended to the following and reference 28 has been updated to link to the journal website.
"A retrospective study from October 2018 to January 2020 evaluated 119 patients who took a CGRP mAb. Some monoclonal antibodies such as erenumab caused constipation in more than 20% of the patients."
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
Footnotes
No competing interests declared.